Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Debt to Equity: 2010-2024

Historic Debt to Equity for Iovance Biotherapeutics (IOVA) over the last 3 years, with Dec 2024 value amounting to $0.00.

  • Iovance Biotherapeutics' Debt to Equity fell 17.71% to $0.00 in Q4 2024 from the same period last year, while for Dec 2024 it was $0.00, marking a year-over-year decrease of 17.71%. This contributed to the annual value of $0.00 for FY2024, which is 17.71% down from last year.
  • Iovance Biotherapeutics' Debt to Equity amounted to $0.00 in Q4 2024, which was down 4.28% from $0.00 recorded in Q1 2024.
  • Iovance Biotherapeutics' 5-year Debt to Equity high stood at $0.00 for Q2 2023, and its period low was $0.00 during Q4 2024.
  • For the 2-year period, Iovance Biotherapeutics' Debt to Equity averaged around $0.00, with its median value being $0.00 (2023).
  • Data for Iovance Biotherapeutics' Debt to Equity shows a maximum YoY dropped of 17.71% (in 2024) over the last 5 years.
  • Quarterly analysis of 2 years shows Iovance Biotherapeutics' Debt to Equity stood at $0.00 in 2023, then decreased by 17.71% to $0.00 in 2024.
  • Its Debt to Equity was $0.00 in Q4 2024, compared to $0.00 in Q1 2024 and $0.00 in Q4 2023.